Evelo Biosciences, Inc.Evelo Biosciences, Inc.Evelo Biosciences, Inc.

Evelo Biosciences, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.14 M‬USD
−13.3502USD
‪−114.53 M‬USD
‪18.90 M‬
Beta (1Y)
80.22

About Evelo Biosciences, Inc.

CEO
Craig R. Jalbert
Headquarters
Cambridge
Employees (FY)
66
Founded
2014
FIGI
BBG00KLJ2SH8
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EVLO is 0.0600 USD — it has increased by ‪9.90 K‬% in the past 24 hours. Watch Evelo Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Evelo Biosciences, Inc. stocks are traded under the ticker EVLO.
EVLO stock has risen by ‪9.90 K‬% compared to the previous week, the month change is a 4.76% fall, over the last year Evelo Biosciences, Inc. has showed a 99.03% decrease.
EVLO reached its all-time high on Jan 28, 2021 with the price of 398.5660 USD, and its all-time low was 0.0005 USD and was reached on May 20, 2024. View more price dynamics on EVLO chart.
See other stocks reaching their highest and lowest prices.
EVLO stock is 99.00% volatile and has beta coefficient of 80.22. Track Evelo Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Evelo Biosciences, Inc. there?
Yes, you can track Evelo Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Evelo Biosciences, Inc. is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
EVLO net income for the last quarter is ‪−12.36 M‬ USD, while the quarter before that showed ‪−21.10 M‬ USD of net income which accounts for 41.41% change. Track more Evelo Biosciences, Inc. financial stats to get the full picture.
No, EVLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2024, the company has 66.00 employees. See our rating of the largest employees — is Evelo Biosciences, Inc. on this list?
Like other stocks, EVLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evelo Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evelo Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evelo Biosciences, Inc. stock shows the sell signal. See more of Evelo Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.